tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXAS Stock Latest News

Cathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings
Market NewsCathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings
9h ago
GH
ABNB
Exact Sciences Corp’s Strong Earnings Call Highlights
PremiumCompany Announcements
Exact Sciences Corp’s Strong Earnings Call Highlights
18h ago
EXAS
Exact Sciences: Strong Financial Performance and Strategic Initiatives Justify Buy Rating
PremiumRatings
Exact Sciences: Strong Financial Performance and Strategic Initiatives Justify Buy Rating
1d ago
EXAS
Exact Sciences price target lowered to $66 from $75 at TD Cowen
PremiumThe Fly
Exact Sciences price target lowered to $66 from $75 at TD Cowen
1d ago
EXAS
EXACT Sciences trading resumes
PremiumThe Fly
EXACT Sciences trading resumes
1d ago
EXAS
EXACT Sciences trading halted, volatility trading pause
PremiumThe FlyEXACT Sciences trading halted, volatility trading pause
1d ago
EXAS
Exact Sciences: Strategic Positioning and Growth Potential Bolstered by Freenome Agreement
Premium
Ratings
Exact Sciences: Strategic Positioning and Growth Potential Bolstered by Freenome Agreement
1d ago
EXAS
Exact Sciences: Strategic Moves and Strong Performance Justify Buy Rating Despite Market Overreaction
Premium
Ratings
Exact Sciences: Strategic Moves and Strong Performance Justify Buy Rating Despite Market Overreaction
1d ago
EXAS
Exact Sciences price target lowered to $55 from $65 at Barclays
PremiumThe Fly
Exact Sciences price target lowered to $55 from $65 at Barclays
1d ago
EXAS
Exact Sciences Corp. Reports Strong Q2 2025 Results
PremiumCompany Announcements
Exact Sciences Corp. Reports Strong Q2 2025 Results
2d ago
EXAS
Closing Bell Movers: DoorDash jumps 8%, Airbnb slips 6% on earnings
PremiumThe Fly
Closing Bell Movers: DoorDash jumps 8%, Airbnb slips 6% on earnings
2d ago
ELF
MCK
Exact Sciences Announces Collaboration with Freenome Holdings
PremiumCompany Announcements
Exact Sciences Announces Collaboration with Freenome Holdings
2d ago
8K
EXAS
Exact Sciences raises 2025 revenue outlook $3.13B-$3.17B
PremiumThe FlyExact Sciences raises 2025 revenue outlook $3.13B-$3.17B
2d ago
EXAS
Exact Sciences acquires Freenome colorectal cancer screening tests
Premium
The Fly
Exact Sciences acquires Freenome colorectal cancer screening tests
2d ago
EXAS
Exact Sciences reports Q2 EPS (1c), consensus (15c)
Premium
The Fly
Exact Sciences reports Q2 EPS (1c), consensus (15c)
2d ago
EXAS
Exact Sciences’ Growth Potential Bolstered by Cologuard Plus and Strategic Medicare Advantage Agreement
PremiumRatings
Exact Sciences’ Growth Potential Bolstered by Cologuard Plus and Strategic Medicare Advantage Agreement
4d ago
EXAS
EXAS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
EXAS Upcoming Earnings Report: What to Expect?
4d ago
EXAS
Exact Sciences expands colorectal cancer screening partnership with Humana
PremiumThe Fly
Exact Sciences expands colorectal cancer screening partnership with Humana
8d ago
HUM
EXAS
Buy Rating for Exact Sciences Driven by Promising CRC Screening Test and Favorable Market Outlook
PremiumRatings
Buy Rating for Exact Sciences Driven by Promising CRC Screening Test and Favorable Market Outlook
17d ago
EXAS
Exact Sciences’ Innovative PCR-Based Blood Test Positions Company for Market Leadership in Colorectal Cancer Screening
PremiumRatingsExact Sciences’ Innovative PCR-Based Blood Test Positions Company for Market Leadership in Colorectal Cancer Screening
21d ago
EXAS
Exact Sciences’ Oncodetect MRD Assay Gains Medicare Coverage, Boosting Long-Term Revenue Potential Amid Competitive Market
Premium
Ratings
Exact Sciences’ Oncodetect MRD Assay Gains Medicare Coverage, Boosting Long-Term Revenue Potential Amid Competitive Market
28d ago
EXAS
Patent board invalidates Exact Sciences patent for stool samples
Premium
The Fly
Patent board invalidates Exact Sciences patent for stool samples
29d ago
EXAS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >